Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Association Between Metabolic Syndrome and Major Adverse Cardiac and Cerebrovascular Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Publisher Pubmed



Hosseini K1, 2 ; Khalaji A1, 2, 3, 4 ; Behnoush AH1, 2, 3, 4 ; Soleimani H1, 2, 4 ; Mehrban S1, 2 ; Amirsardari Z1, 2, 5 ; Najafi K6 ; Fathian Sabet M7 ; Hosseini Mohammadi NS1, 2, 3 ; Shojaei S1, 2, 3 ; Masoudkabir F1, 2 ; Aghajani H1, 2 ; Mehrani M1, 2 ; Razjouyan H8 Show All Authors
Authors
  1. Hosseini K1, 2
  2. Khalaji A1, 2, 3, 4
  3. Behnoush AH1, 2, 3, 4
  4. Soleimani H1, 2, 4
  5. Mehrban S1, 2
  6. Amirsardari Z1, 2, 5
  7. Najafi K6
  8. Fathian Sabet M7
  9. Hosseini Mohammadi NS1, 2, 3
  10. Shojaei S1, 2, 3
  11. Masoudkabir F1, 2
  12. Aghajani H1, 2
  13. Mehrani M1, 2
  14. Razjouyan H8
  15. Hernandez AV9, 10
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Hakim Children Hospital, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. School of Medicine, Babol University of Medical Sciences, Babol, Iran
  8. 8. Department of Medicine, Penn State College of Medicine, Hershey, PA, United States
  9. 9. Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT, United States
  10. 10. Unidad de Revisiones Sistematicas y Meta-Analisis (URSIGET), Vicerrectorado de Investigacion, Universidad San Ignacio de Loyola, Lima, Peru

Source: Scientific Reports Published:2024


Abstract

Metabolic syndrome (MetS) poses an additional risk for the development of coronary artery disease and major adverse cardiac and cerebrovascular events (MACCE). In this study, we investigated the association between MetS and its components and MACCE after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). The presence of MetS was calculated at baseline using the NCEP-ATP III criteria. The primary outcome was MACCE and its components were secondary outcomes. Unadjusted and adjusted Cox Regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CI) of the association between MetS or its components and MACCE and its components. A total of 13,459 ACS patients who underwent PCI (MetS: 7939 and non-MetS: 5520) with a mean age of 62.7 ± 11.0 years (male: 72.5%) were included and median follow-up time was 378 days. Patients with MetS had significantly higher MACCE risk (adjusted HR [aHR] 1.22, 95% CI 1.08–1.39). The only component of MACCE that exhibited a significantly higher incidence in MetS patients was myocardial infarction (aHR 1.43, 95% CI 1.15–1.76). MetS components that were significantly associated with a higher incidence of MACCE were hypertension and impaired fasting glucose. Having three MetS components did not increase MACCE (aHR 1.12, 95% CI 0.96–1.30) while having four (aHR 1.32, 95% CI 1.13–1.55) or five (aHR 1.42, 95% CI 1.15–1.75) MetS components was associated with a higher incidence of MACCE. MetS was associated with a higher risk of MACCE in ACS patients undergoing PCI. Among MACCE components, myocardial infarction was significantly higher in patients with MetS. Impaired fasting glucose and hypertension were associated with a higher risk of MACCE. Identifying these patterns can guide clinicians in choosing appropriate preventive measures. © 2024, The Author(s).
Experts (# of related papers)
Other Related Docs
19. Dietary Fiber and Aging, Nutrients and Nutraceuticals for Active and Healthy Ageing (2020)